Distinct plasma immune signatures in ME/CFS are present early in the course of illness
about
Myalgic Encephalomyelitis: Symptoms and BiomarkersIllness progression in chronic fatigue syndrome: a shifting immune baselineThe biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problemFrom good health to illness with post-infectious fatigue syndrome: a qualitative study of adults' experiences of the illness trajectory.Abnormal Resting-State Functional Connectivity in Patients with Chronic Fatigue Syndrome: Results of Seed and Data-Driven Analyses.Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndromeExamining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic reviewMetabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndromeEfficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance TreatmentSleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot studyReduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.A Pair of Identical Twins Discordant for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Differ in Physiological Parameters and Gut Microbiome Composition.Fibromyalgia syndrome in need of effective treatments.Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.Replacing Myalgic Encephalomyelitis and Chronic Fatigue Syndrome with Systemic Exercise Intolerance Disease Is Not the Way forwardThe Relationship between Age and Illness Duration in Chronic Fatigue SyndromeFatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokinesInterleukin-1 as a mediator of fatigue in disease: a narrative review.Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.Cytokine signature associated with disease severity in chronic fatigue syndrome patients.Telephone-administered versus live group cognitive behavioral stress management for adults with CFS.RNA-Seq Analysis of Gene Expression, Viral Pathogen, and B-Cell/T-Cell Receptor Signatures in Complex Chronic Disease.Association of mitochondrial DNA variants with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) symptoms.Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings.Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations.Reversal of Refractory Ulcerative Colitis and Severe Chronic Fatigue Syndrome Symptoms Arising from Immune Disturbance in an HLA-DR/DQ Genetically Susceptible Individual with Multiple Biotoxin Exposures.Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment.Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons.Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.A Molecular Neurobiological Approach to Understanding the Aetiology of Chronic Fatigue Syndrome (Myalgic Encephalomyelitis or Systemic Exertion Intolerance Disease) with Treatment Implications.Inflammation correlates with symptoms in chronic fatigue syndrome.Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.Association of chronic fatigue syndrome with premature telomere attrition.Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection.Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
P2860
Q26786545-4B3EC071-68E3-465D-9D2D-FF4031EF4B02Q28389279-4C6DF2FB-9B5B-4F52-AEAC-8CB3B32200CAQ28394255-84E399DF-85C3-4B5C-B9CD-9A586EEB35BFQ30843149-3B14C29A-D217-48BF-8F25-0503D34F631EQ31003423-32535712-5D9E-4B2A-9CC6-F0C7F61DCD2EQ33604317-855F4E17-4A09-4F7A-B419-79F61236E811Q33776463-F2871E77-E5E0-44BC-9B52-8BA10750B2D5Q34161527-6A416CCD-A7B0-42A5-93AD-77D04906B59BQ34520840-63CE9DB0-88D0-48A3-968E-2DA155C4BF13Q35680023-764DF9FE-2A46-453E-B4C8-BBF36AEC4946Q35896707-B4827664-0E4D-407D-9223-0F5C29A70C4DQ36060516-EE36540D-41D8-4955-A6D9-1EA310440625Q36106681-AED15D59-6B92-4788-A0AD-1AD6F47F01A9Q36158720-20E0BAA3-2A1D-404F-9AAB-8FCBC889F75EQ36186172-9FF48861-D9DB-4763-AAB9-C037839CC756Q36189738-3BA85794-D47E-41CC-804B-FECE74E6E6E9Q36480750-AAE3A9DD-7654-4456-9C10-5C6A1D991B8BQ36731913-835BFF78-60C9-4B36-BE95-5A5919C35EA6Q37061432-076C44F9-7C6E-4BDA-8EB4-B5D2ABB74DE2Q37133826-AFDAAC8D-2257-43C7-891A-543BAB4803ACQ37597282-8325E704-0480-4D77-8AC6-347727B2D065Q38650323-02E9AC59-464E-4BC7-8F13-A403FC5CD54CQ38650803-09BE7FEC-A8CD-49BC-AE25-0B26ADA004EDQ38767944-95D502DA-14A6-486B-9349-FEC4BCD51A48Q38973903-AF980FAC-330B-481F-AB4C-6A7B9573B1EFQ39081948-EF6ED89A-7616-4E54-8CFF-E6EC7741F691Q39100152-3BD63113-8495-4F6F-8C66-F6A7F373DA49Q40259234-7D5C52FC-F4B8-4008-9C79-F6D60704B15AQ42054198-6FB15038-4DB0-4CAD-9101-A325F553BA5FQ47144415-E83DDBAF-0093-489B-9813-6121EDE59336Q47988167-1357B9A2-BB8E-41A7-9AEB-CC3006A69027Q48096334-0CF964F4-1A4F-4E1D-9B00-2FB08A822D7CQ49298029-D3BEC7DC-0A50-4757-AF5E-E3C0B474D254Q50145916-20139884-0C97-48D2-8171-74BD95B0F642Q50326870-2AC309D2-479E-4294-8356-C861963BB4D6Q50333926-9A081900-1F6D-41AA-8BB5-EB088275CC06Q50689763-0AC66E2E-6335-4249-97D4-DA0214EE0FA8Q51766849-C598B142-ABDC-48E0-8C3D-4396F8BE8914Q53412073-371E9B8C-8E15-4CD5-8D6D-CD0A8737123CQ55387468-B7B8E378-CFE2-4C9F-B1D0-334425D24E46
P2860
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@ast
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@en
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@nl
type
label
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@ast
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@en
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@nl
prefLabel
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@ast
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@en
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
@en
P2093
Andrew F Schultz
Anthony L Komaroff
C Gunnar Gottschalk
Daniel L Peterson
Donna Felsenstein
José G Montoya
Meredith L Eddy
Susan Levine
Xiaoyu Che
P2860
P304
e1400121-e1400121
P3181
P356
10.1126/SCIADV.1400121
P407
P577
2015-02-01T00:00:00Z